The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Brown G. 5‐Aminosalicylic acid–associated myocarditis and pericarditis: a narrative review. Can J Hosp Pharm 2016; 69: 466.
- 2. Sehgal P, Colombel JF, Aboubakr A, Narula N. Systematic review: safety of mesalazine in ulcerative colitis. Aliment Pharmacol Ther 2018; 47: 1597‐1609.
- 3. Varnavas VC, Reinsch N, Perrey M, et al. Recurrent lymphocytic myocarditis in a young male with ulcerative colitis. Eur J Med Res 2014; 19: 11.
- 4. Fleming K, Ashcroft A, Alexakis C, et al. Proposed case of mesalazine‐induced cardiomyopathy in severe ulcerative colitis. World J Gastroenterol 2015; 21: 3376‐3379.
- 5. Friedrich MG, Sechtem U, Schulz‐Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009; 53: 1475‐1487.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.